Patel Naimish insider trades
Patel Naimish has filed 12 Form 4s with the SEC that we hold, for CRISPR Therapeutics AG (CRSP) (Chief Medical Officer) and AgomAb Therapeutics NV (AGMB) (Director). Across all of them we count 1 purchase worth $49.7K and 3 sales worth $503.9K reported on Form 4. In the last 12 months: 0 purchases ($0) and 2 sales ($362.6K). The largest single trade was a sale of 3,786 shares of CRISPR Therapeutics AG worth $210.6K, dated 2026-05-29. The first filing on our record is dated 2024-05-29 and the latest 2026-09-15.
CRISPR Therapeutics AG (CRSP)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2025-04-03 | P, purchase reported on Form 4 | 1,508 | $49.7K | 2026-01-27 |
| 2025-05-29 | S, sale reported on Form 4 | 3,932 | $141.3K | 2025-05-30 |
| 2026-03-16 | S, sale reported on Form 4 | 3,150 | $152.0K | 2026-03-17 |
| 2026-05-29 | S, sale reported on Form 4 | 3,786 | $210.6K | 2026-06-01 |
AgomAb Therapeutics NV (AGMB)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 2021679) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms